Evidence map›Paper›PMID 29370404›Full record

ArticleSchizophrenia bulletin2019

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure.

Johnny Downs, Harry Dean, Suzannah Lechler, Nicola Sears, Rashmi Patel, Hitesh Shetty, Matthew Hotopf, Tamsin Ford, Marinos Kyriakopoulos, Covadonga M Diaz-Caneja and 4 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Johnny DownsDepartment of Psychological Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London & NIHR South London and Maudsley Biomedical Research Centre, UK.
Harry DeanDepartment of Psychological Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London & NIHR South London and Maudsley Biomedical Research Centre, UK.
Suzannah LechlerDepartment of Psychological Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London & NIHR South London and Maudsley Biomedical Research Centre, UK.
Nicola SearsDepartment of Psychological Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London & NIHR South London and Maudsley Biomedical Research Centre, UK.
Rashmi PatelSouth London and Maudsley NHS Foundation Trust, UK.
Hitesh ShettySouth London and Maudsley NHS Foundation Trust, UK.
Matthew HotopfDepartment of Psychological Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London & NIHR South London and Maudsley Biomedical Research Centre, UK.
Tamsin FordUniversity of Exeter Medical School, UK.
Marinos KyriakopoulosSouth London and Maudsley NHS Foundation Trust, UK.
Covadonga M Diaz-CanejaChild and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Spain.
Celso ArangoChild and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, CIBERSAM, Spain.
James H MacCabeSouth London and Maudsley NHS Foundation Trust, UK.
Richard D HayesDepartment of Psychological Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London & NIHR South London and Maudsley Biomedical Research Centre, UK.
Laura Pina-CamachoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry Psychology and Neuroscience, King's College London, UK.

Funding

Medical Research Council MR/J01219X/1Medical Research Council MR/K002813/1Medical Research Council MR/L011794/1Medical Research Council MR/L017105/1Medical Research Council MR/S003118/1
6 · The paper itself

Abstract

The prevalence of negative symptoms (NS) at first episode of early-onset psychosis (EOP), and their effect on psychosis prognosis is unclear. In a sample of 638 children with EOP (aged 10-17 y, 51% male), we assessed (1) the prevalence of NS at first presentation to mental health services and (2) whether NS predicted eventual development of multiple treatment failure (MTF) prior to the age of 18 (defined by initiation of a third trial of novel antipsychotic due to prior insufficient response, intolerable adverse-effects or non-adherence). Data were extracted from the electronic health records held by child inpatient and community-based services in South London, United Kingdom. Natural Language Processing tools were used to measure the presence of Marder Factor NS and antipsychotic use. The association between presenting with ≥2 NS and the development of MTF over a 5-year period was modeled using Cox regression. Out of the 638 children, 37.5% showed ≥2 NS at first presentation, and 124 (19.3%) developed MTF prior to the age of 18. The presence of NS at first episode was significantly associated with MTF (adjusted hazard ratio 1.62, 95% CI 1.07-2.46; P = .02) after controlling for a number of potential confounders including psychosis diagnostic classification, positive symptoms, comorbid depression, and family history of psychosis. Other factors associated with MTF included comorbid autism spectrum disorder, older age at first presentation, Black ethnicity, and family history of psychosis. In EOP, NS at first episode are prevalent and may help identify a subset of children at higher risk of responding poorly to antipsychotics.

Indexed as

Treatment FailureAdolescentAdolescent Health ServicesAge of OnsetAntipsychotic AgentsChildChild Health ServicesElectronic Health RecordsFemaleFollow-Up StudiesHumansLondonMaleMental Health ServicesNatural Language ProcessingOutcome Assessment, Health CareAntipsychotic Agents

Identifiers

PMID29370404
PMCPMC6293208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.